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OBJECTIVE — A low–glycemic index diet is effective as a treatment for individuals with
diabetesandhasbeenshowntoimprovepregnancyoutcomeswhenusedfromtheﬁrsttrimester.
A low–glycemic index diet is commonly advised as treatment for women with gestational
diabetes mellitus (GDM). However, the efﬁcacy of this advice and associated pregnancy out-
comes have not been systematically examined. The purpose of this study was to determine
whether prescribing a low–glycemic index diet for women with GDM could reduce the number
of women requiring insulin without compromise of pregnancy outcomes.
RESEARCHDESIGNANDMETHODS — AllwomenwithGDMseenovera12-month
period were considered for inclusion in the study. Women (n  63) were randomly assigned to
receive either a low–glycemic index diet or a conventional high-ﬁber (and higher glycemic
index) diet.
RESULTS — Of the 31 women randomly assigned to a low–glycemic index diet, 9 (29%)
required insulin. Of the women randomly assigned to a higher–glycemic index diet, a signiﬁ-
cantly higher proportion, 19 of 32 (59%), met the criteria to commence insulin treatment (P 
0.023). However, 9 of these 19 women were able to avoid insulin use by changing to a low–
glycemic index diet. Key obstetric and fetal outcomes were not signiﬁcantly different.
CONCLUSIONS — Using a low–glycemic index diet for women with GDM effectively
halved the number needing to use insulin, with no compromise of obstetric or fetal outcomes.
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G
estational diabetes mellitus (GDM) is
deﬁned as any degree of glucose in-
tolerance with onset or ﬁrst recogni-
tion during pregnancy (1). GDM is
associated with an increase in adverse
pregnancy outcomes, and the advantages
oftreatmentontheseoutcomeshavebeen
identiﬁed (2). All women with GDM
should have medical nutrition therapy
(MNT) with the objective of achieving
and maintaining blood glucose levels as
close to the normal range as possible (3).
MNT needs to be individualized and
should be based on carbohydrate (CHO)
distribution and ideally on the results of
self-monitoringofbloodglucose(SMBG).
ForthepurposesofSMBG,acombination
of the fasting and postprandial glucose
levels is desirable.
When MNT alone is unable to keep
the results of SMBG within predeter-
mined target ranges, alternative therapies
are required. Although there is some evi-
dence that both glyburide (4) and met-
formin(5)canbeused,theoverwhelming
experience has been with insulin. How-
ever, the potential use of insulin can be a
sourceofbothanxietyandofresistanceto
treatment change.
In normal subjects, mixed meals
based on low–glycemic index foods lead
to a reduction in postprandial glycemia
(6). We have previously demonstrated in
normal pregnant women that a diet based
on low–glycemic index foods was sus-
tainable and resulted in more favorable
fetal outcomes (7). The aim of this study
was to examine whether a low–glycemic
index diet used as MNT for women with
GDM could result in a reduced need for
insulin use during pregnancy with no
compromise of obstetric and fetal
outcomes.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted in the city of Wollongong, New
South Wales, Australia, a coastal city with
a population of 280,000 people situ-
ated about 50 miles south of Sydney. The
Australasian Diabetes in Pregnancy Soci-
ety (ADIPS) recommends that all preg-
nant women should be tested for GDM
(8). Unless indicated earlier, women have
a 75-g glucose tolerance test at the begin-
ning of the third trimester with glucose
samples taken after fasting and at 2 h.
GDM is diagnosed if the fasting glucose is
5.5 mmol/l (100 mg/dl) and/or the
2-hglucoseis8.0mmol/l(145mg/dl)
(9). Virtually all women with GDM are
seen at the Diabetes Center by a diabetes
nurse educator and a specialist dietitian.
All women seen over a 12-month period
(October 2007–September 2008) were
considered. There are 3,300 deliveries
each year in the area, including those in
boththepublicandprivatehospitals.The
prevalence of GDM is 7%, and there is
90% compliance with universal testing
(10).
Inclusion criteria were age 18–40
years(inclusive),singletonpregnancy,no
previous GDM, nonsmoker, diagnosis of
GDM and seen for the ﬁrst dietary visit
between 28 and 32 weeks of gestation,
and ability to follow the protocol require-
ments. Exclusion criteria included any
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glucoselevelsandunwillingnesstofollow
the prescribed diet.
After diagnosis of GDM and assess-
ment by a physician (R.G.M.), all women
attendedtheDiabetesCenter.Iftheywere
potentially interested in the study, they
were asked to complete a 3-day food
record before the ﬁrst visit with the dieti-
tian. This record was used for the initial
dietary assessment. The visit was com-
pleted between 28 and 32 weeks of gesta-
tion.Visits2and3wereconducted1–2
and 3–4 weeks, respectively, after the
initial visit and included a 7-day food
recordthatwasusedtocalculateglycemic
index. The ﬁnal visit was at 35–37 weeks
of gestation with a 3-day food record that
wasusedtocomparewiththefoodrecord
at visit 1. Thus, all women were seen at
leastfourtimesfordietaryassessmentand
iftheyrequiredinsulinwereseenasmany
times as necessary for insulin adjustment.
Weight was measured to the nearest
0.1 kg on ﬂoor scales (HD-316, Wedder-
burn Scales; Tanita Corporation, Tokyo,
Japan) with subjects dressed in light
clothes and without shoes. Height was
measured to the nearest 0.1 cm against a
wall using a nonstretchable ﬁberglass
measuring tape (Gulick II; Country Tech-
nology, Gays Mils, WI).
Women who met the inclusion crite-
ria and had no exclusions were randomly
assigned to receive one of two different
diets using permuted blocks of unequal
size with the list generated using STATA
(version 7.0). Both diets were compatible
with the recommended nutritional intake
in pregnancy (9). The CHO intake was
designed to achieve a minimum of 175
g/day with only the recommended choice
of CHO foods varying. The dietary advice
was individualized with speciﬁc mention
of the energy and nutrient balance to
achieve normal weight gain during the
third trimester. The low–glycemic index
diet was based on previously veriﬁed
low–glycemic index food (11), including
pasta, grain breads, and unprocessed
breakfastcerealswithahighﬁbercontent.
Women were speciﬁcally asked to avoid
consuming white bread, processed com-
mercial breakfast cereals, potatoes, and
some rice varieties. Women in the con-
ventional, higher–glycemic index diet
group were advised to follow a diet with a
high-ﬁberandlow-sugarcontent,withno
speciﬁc mention of the glycemic index.
Potatoes,wholewheatbread,andspeciﬁc
high-ﬁber, moderate-to-high–glycemic
index breakfast cereals were recom-
mended. During clinic visits, the dietitian
referred to the diets as the “low–glycemic
index diet” or the “high-ﬁber/low-sugar”
diet. Participants were provided with a
bookletoutliningtheCHOchoicesaswell
as the CHO food amounts constituting
one serving (based on 15-g portions). To
assist with achieving stable blood glucose
levels throughout the day, participants
were advised to consume three small
mealsandtwotothreesnackswithaspec-
iﬁed number of servings of CHOs. Study
dietitians were not blinded to dietary as-
signment but were aware of the need for
impartiality and equivalent treatment. The
physiciancaringforthepatientswasnotin-
formed of the diet allocation.
Women were provided with a home
glucose meter (Accu-Check Performa;
Roche)andwereaskedtotestafterfasting
and1hafterthestartofeachoftheirthree
majormealsatleasteverysecondday.The
use of insulin, unless there were excep-
tional circumstances, was advised if more
than once a week the fasting glucose was
5.5 mmol/l and/or the 1-h postprandial
glucose was 8.0 mmol/l. For women
consuming the low–glycemic index diet
who exceeded these values, insulin was
started immediately. Women consuming
the higher–glycemic index diet who ex-
ceeded these values were changed to a
low–glycemic index diet, and their re-
sponses were reviewed over a week.
When indicated, insulin treatment was
initiated with twice-daily premixed insulin
(NovoMix 30, Novo Nordisk) using a dis-
posable pen device. The dose was ad-
justedregularlytoachieveglycemicgoals.
Food intake data for the baseline
visit,visit2,visit3,andtheﬁnalvisitfor
each participant were entered into a
customized database incorporating the
Australian food composition tables and
published glycemic index values using
the glucose  100 scale (FoodWorks
Professional,version42005;XyrisSoft-
ware, Highgate Hill, QLD, Australia).
When necessary, additional glycemic
index data were obtained from an on-
line database (http://www.glycemic
index.com). Overall, the dietary glycemic
index was calculated as the sum of the
weightedglycemicindexofallCHOfoods
in the diet, with the weighting propor-
tional to the contribution of each food to
the total CHO intake. Because the target
diets aimed for a similar carbohydrate
content,glycemicload(theproductofthe
glycemic index and the amount of CHO)
was inﬂuenced only by differences in gly-
cemic index.
Pregnancy care was the responsibility
of the obstetric health care providers and
was conducted in accord with standard
practice. Because both diets were within
the nutritional guidelines for pregnancy,
the obstetric health care providers were
not speciﬁcally informed of the diet allo-
cation. Obstetric outcomes, including
birth weight, fetal length and head cir-
cumference, Apgar score, and method of
delivery, were obtained from the medical
record. For comparison between the two
groups, the fetal centile was calculated
fromhttp://www.gestation.netusingAus-
tralian data. By this means the birth
weight was adjusted for sex, gestational
week of delivery, and maternal age, par-
ity, height, and prepregnancy weight by
recall.Theponderalindexofthebabywas
calculated using the following formula:
weight in grams divided by the cube of
length in centimeters and multiplied by
100. The BMI of the mother was calcu-
lated by dividing weight at enrollment in
kilograms by the square of height in
meters. The Illawarra Area Health Service
and University of Wollongong Human
Research Committee approved the re-
search, and participants gave written in-
formed consent.
Statistical analysis
Independent samples t tests were used to
compare the dietary components and the
glycemic index, glycemic load, and CHO
values of the low–glycemic index and the
high–glycemic index groups at the vari-
ous appointment times. Pearson 
2 tests
of independence were used to compare
proportions identiﬁed as needing insulin
and actually starting on insulin in the
low–glycemic index and high–glycemic
index groups. SPSS (version 14; SPSS,
Chicago, IL) was used for all statistical
analyses. Unless otherwise stated, results
are expressed as means  SEM. Results
were considered signiﬁcant if P  0.05.
RESULTS— This study recruited for a
12-month period starting in October
2007. Over this period 212 women with
GDM were seen, of whom 63 met the cri-
teria and agreed to participate in the
study; 31 were randomly assigned to re-
ceivethelow–glycemicindexdiet,and32
were randomly assigned to receive the
high-ﬁber/low-sugar diet (henceforth re-
ferred to as the high–glycemic index
diet). All women except one were Cauca-
sian.Therewerenosigniﬁcantdifferences
in the baseline characteristics of the two
groups as outlined in Table 1.
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each diet group and their insulin require-
ments is shown in Fig. 1. In summary, the
number of women in the low–glycemic in-
dex group who met the criteria to start on
insulin (9 of 31 [29%]) was signiﬁcantly
lower than 19 of 32 women (59%) as seen
in the high–glycemic index diet (P 
0.023). Of the 19 women in the high–
glycemic index group who met the criteria
to start insulin and were then switched to
the low–glycemic index diet, 9 no longer
met the criteria to start insulin. Thus, after
dietary changes, only 10 of 32 (31%) of the
women in the high–glycemic index group
required insulin, and that number was not
signiﬁcantly different from the 9 of 31
(29%) in the original low–glycemic index
group. Insulin was initiated at 32.1  0.4
weeks for women in the low–glycemic in-
dex group and at 32.3  0.5 weeks for
women in the high–glycemic index group
(P0.83).Thetotaldailydoseofinsulinat
term was 24  2.2 units.
The reported dietary intakes assessed
by a 3-day food record at baseline and at
the ﬁnal visit of the study are shown in
Table 2. There were no signiﬁcant differ-
ences between the two groups at baseline
with respect to energy and most nutrients
except for a higher percentage of energy
from protein in the women randomly as-
signed to the high–glycemic index group
(P  0.009). Between the baseline and
ﬁnal visits there was a signiﬁcant reduc-
tion in total energy consumed in both
groups due mainly to a reduction in the
CHO intake. There were no signiﬁcant
differences in the extent of this reduction
between the two groups. The amount of
protein consumed as a percentage of en-
ergy intake increased signiﬁcantly for
both groups over the course of the study.
The percentage of energy intake for
monounsaturated fats, polyunsaturated
fats, and saturated fats was not signiﬁ-
cantly different between the groups and
did not change during the study (data not
shown).
The glycemic index for all visits is
shown in Table 3. The glycemic index at
baseline was similar in both groups. The
women randomly assigned to the low–
glycemic index diet achieved and main-
tained a signiﬁcantly lower glycemic
index at all stages. The women randomly
assigned to the high–glycemic index diet,
who did not meet the criteria to start in-
sulin and, hence, had no diet changes,
had no signiﬁcant change in glycemic in-
dex during the course of the study. The
women randomly assigned to the high–
glycemic index diet, who met the criteria
to start insulin and were changed to a
low–glycemic index diet (usually at or
shortlyaftervisit2),achievedasigniﬁcant
reductioninglycemicindexbyvisit3and
had a glycemic index value similar to that
of the original low–glycemic index group
by the ﬁnal visit.
There were no signiﬁcant differences
between the women in either group with
respect to weight gain from baseline to
delivery, induction of labor, method of
delivery, or gestational age at delivery
(data not shown). For women in the low–
glycemic index group, the birth centile
(46.3  5.0) and ponderal index (2.7 
0.05)werenotsigniﬁcantlydifferentfrom
the birth centile (54.3  4.8, P  0.25)
and ponderal index (2.6  0.04, P 
0.12)forwomeninthehigh–glycemicin-
dex diet group. Three women in both
groups had a large-for-gestational-age
baby (90th centile), and two women in
the low–glycemic index group had a
small-for-gestational-age baby (10th
centile).Overall,therewerenosigniﬁcant
differencesinobstetricandfetaloutcomes
between the two groups.
Theobstetricandfetaloutcomeswere
further analyzed with respect to compar-
ing women who were and were not re-
ceivinginsulinfor1)womenconsuminga
low–glycemic index diet, 2) women con-
suming a high–glycemic index diet, and
3) the two groups combined. There were
no signiﬁcant differences with respect to
induction of labor, method of delivery,
fetalcentile,andponderalindex(datanot
shown).
CONCLUSIONS — Two recent reports
have shown the advantages of a low–
glycemic index diet for the management
of individuals with type 2 diabetes
(12,13). Although evidence about the
usefulness of a low–glycemic index diet
inpregnancyislimited(14),wehavepre-
viously shown that consumption of a
low–glycemic index diet from the begin-
ning of the second trimester resulted in
better fetal outcomes (7). The usual prac-
tice in our clinic has been to encourage
Figure 1—Flowchart of the number of women in each diet group and the number requiring
insulin. HGI, higher–glycemic index diet; LGI, low–glycemic index diet.
Table 1—Baseline characteristics of the women
Low–glycemic
index group
High–glycemic
index group P value*
n 31 32
Age (years) 30.8  0.7 31.3  0.8 0.68
Weight at enrollment (kg) 83.1  3.2 86.9  3.6 0.43
BMI at enrollment (kg/m
2) 32.0  1.2 32.8  1.4 0.68
Parity 0.84  0.17 0.78  0.18 0.82
Oral glucose tolerance test (mmol/l)†
Fasting glucose 4.6  0.1 4.7  0.1 0.49
2-h glucose 8.4  0.2 8.4  0.1 0.83
Gestational age at entry to study (weeks) 30.3  0.2 29.9  0.2 0.23
Data are means  SEM. *Comparison of the low–glycemic index group with the high–glycemic index
group, independent samples t test. †2-h, 75-g glucose load.
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ingMNTtowomenwithGDM.However,
this recommendation was based on clini-
cal experience and had not been formally
examined. We therefore decided to ex-
tend the observations about the potential
beneﬁts of a low–glycemic index diet in
pregnancy to women with GDM.
It was impossible to blind women to
theglycemicindexconcept,asitiswidely
knownanddiscussedinthelaypress.The
study criteria excluded any woman who
was unwilling to follow the prescribed
diet. The standard literature about GDM
that was provided to all women was
rewritten to remove reference to the gly-
cemic index of food. During recruitment
and the consent process, it was carefully
explained to all women that the best diet
for the treatment of GDM was not known
andthatﬁndingthebestdietwasthepur-
pose of the study.
Womenrandomlyassignedtoreceive
a low–glycemic index diet were able to
lowertheglycemicindexoftheirdietrap-
idly and maintain this lower level for
the duration of pregnancy. Women who
were consuming a higher–glycemic in-
dex diet and, because they met the cri-
teria to start insulin, were advised to
change to a low–glycemic index diet
also achieved this lower level rapidly
and were able to maintain it for the du-
ration of the pregnancy. The ﬁnal glyce-
mic index in both groups consuming a
low–glycemic index diet was not signif-
icantly different. Fiber intake, which
sometimeshasbeenaconfoundingvari-
ableindeterminingthepotentialadvan-
tages of a low–glycemic index diet, was
similar in both groups. Both groups of
women self-restricted their energy in-
Table 2—Reported dietary intake assessed by 3-day food record at baseline and the ﬁnal visit
Low–glycemic
index group
High–glycemic index
group, no insulin
High–glycemic index
to low–glycemic
index group P value* P value†
n 31 13 (ﬁnal 12) 19 (ﬁnal 18)
Energy (cal)
Baseline visit 1,994  72 1,932  146 1,914  88 0.50 0.91
Final visit 1,713  66 1,664  79 1,651  73 0.63 0.91
Change (P value‡) 281  79 (0.001) 251  140 (0.10) 262  119 (0.042)
Protein (% energy)
Baseline visit 18.4  0.6 20.9  1.3 21.7  1.2 0.009 0.64
Final visit 23.9  0.7 23.5  0.8 24.4  0.7 0.51 0.41
Change (P value‡) 5.5  0.9 (0.001) 2.2  1.1 (0.070) 2.7  1.2 (0.041)
Carbohydrate (% energy)
Baseline visit 45.0  1.0 42.2  1.1 45.1  2.0 0.50 0.28
Final visit 36.7  1.1 37.8  1.1 35.1  1.5 0.80 0.21
Change (P value†) 8.3  1.1 (0.001) 4.3  1.3 (0.006) 10.4  2.5 (0.001)
Fat (% energy)
Baseline visit 31.7  0.8 32.5  1.3 31.7  1.7 0.81 0.74
Final visit 33.4  1.1 34.0  1.2 34.5  1.8 0.57 0.79
Change (P value‡) 1.7  1.0 (0.11) 1.6  1.7 (0.36) 3.0  2.2 (0.19)
Fiber (g)
Baseline visit 25.4  1.3 23.1  1.2 24.0  1.5 0.30 0.66
Final visit 25.6  1.3 22.9  1.1 22.3  1.6 0.13 0.77
Change (P value‡) 0.3  1.4 (0.86) 0.3  1.5 (0.84) 1.9  1.7 (0.28)
Data are means  SEM. *Comparison of low–glycemic index group with high–glycemic index group (high–glycemic index groups combined). †Comparing those
whochangedtoalow–glycemicindexdietwiththosecontinuingtoconsumeahigh–glycemicindexdiet.‡Comparisonsfrombaselinetoﬁnalvisit(§forthosewith
baseline and ﬁnal visits only).
Table 3—Glycemic index at all visits
Low–glycemic index
group
High–glycemic index group
P value* P value†
Did not meet
criteria for insulin
use
Met criteria for insulin use
and changed to low–
glycemic index diet
n 31 13 19
Baseline visit 57.3  0.9 57.9  1.5 57.4  1.2 0.83 0.79
Visit 2 49.2  0.9‡ 56.9  1.1 57.9  1.0 0.001 0.53
Visit 3 48.7  0.9‡ 58.2  0.7§ 52.2  1.4 0.001 0.001
Final visit 48.0  0.9 56.0  1.1§ 49.6  1.1 0.018 0.001
Change: baseline to ﬁnal visit (P value) 8.4  1.0 (0.001) 1.5  1.6 (0.38) 7.9  1.1 (0.001)
Data are means  SEM. *Comparison of low–glycemic index with high–glycemic index groups (combined). †Comparing those who changed to a low–glycemic
index diet with those continuing to consume a high–glycemic index diet. ‡n  30. §n  12. n  18.
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amount of CHOs consumed.
Women randomly assigned to ini-
tially consume a low–glycemic index diet
had a signiﬁcantly lower rate of insulin
use. All women consuming the higher
glycemic index diet who met the criteria
to start insulin were changed to a low–
glycemic index diet, and about half no
longer met the criteria to start insulin and
thus were able to avoid its use.
Insulin use for the women with higher
glycemic levels resulted in fetal centile and
ponderalindexesthatwerenotsigniﬁcantly
different from those in the diet-treated
groups. In contrast to our previous study in
normal women, the low–glycemic index
diet for women with GDM did not result in
asigniﬁcantlylowerfetalcentileorponderal
index.Itisveryprobablethatthisresultwas
relatedtotheshorterdurationofthedietfor
women with GDM compared with women
starting the diet during the ﬁrst trimester.
However,demonstrationofadifferencewas
nottheprimaryaimofthestudy,anditwas
not powered for this purpose. Although a
trend was apparent, it is possible that a
longer duration of a low–glycemic index
diet may be required.
In summary, a low–glycemic index
diet for women with GDM is safe, well tol-
erated,andsustainable.Alow–glycemicin-
dex diet signiﬁcantly reduces the need for
the use of insulin without compromise of
obstetric or fetal outcomes.
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